Christopher Chow, DPM
Foot & Ankle Surgery · New York, NYNPI 1619985181
Payments from drug & device makers
Across 146 payments — averaging $59.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gotham Surgical Solutions & Devices, Inc.$2K
- Treace Medical Concepts, Inc.$1K
- Advanced Oxygen Therapy Inc.$1K
- IBSA Pharma Inc.$1K
- Stryker$630
- Amgen$490
- plus $2K from 26 others
What the payments were for
- Consulting fees$7509%
- Travel & lodging$5456%
- Food & beverage$5,78667%
- Education$1,53618%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gotham Surgical Solutions & Devices, Inc. | 1 | $1,536 |
| Treace Medical Concepts, Inc. | 20 | $1,498 |
| Advanced Oxygen Therapy Inc. | 16 | $1,283 |
| IBSA Pharma Inc. | 13 | $1,076 |
| Stryker(2 entities) | 13 | $630 |
| Amgen(2 entities) | 14 | $490 |
| Smith+Nephew | 20 | $391 |
| Kowa Pharmaceuticals America, Inc. | 12 | $180 |
| Paratek Pharmaceuticals, Inc. | 8 | $142 |
| Kerecis Limited | 1 | $141 |
| Lifenet Health | 1 | $134 |
| Merck | 1 | $125 |
| Gilead | 1 | $125 |
| Misonix Inc | 1 | $118 |
| Sanara Medtech Inc. | 1 | $117 |
| Pfizer | 4 | $84 |
| Nevro Corp. | 2 | $82 |
| Johnson & Johnson | 1 | $81 |
| Medtronic | 1 | $57 |
| Averitas Pharma Inc. | 2 | $49 |
| Zimmer Biomet | 1 | $36 |
| Paragon 28, Inc. | 1 | $30 |
| Bioventus LLC | 1 | $29 |
| Solventum Corporation | 1 | $28 |
| Vertex | 1 | $25 |
| Orthofix Medical, Inc. | 1 | $22 |
| KCI USA, Inc. | 1 | $21 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $21 |
| Integra Lifesciences Corporation | 1 | $19 |
| Organogenesis Inc. | 1 | $17 |
| Fidia Pharma USA Inc. | 2 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Topical oxygen chamber for extremities$1,031
- Licart$875
- Kerecis SurgiClose$565
- LAPIPLASTY SYSTEM 1$522
- Lapiplasty System$321
- TMC NANOPLASTY SYSTEM$249
- PROstep$170
- Kerecis GraftGuide$141
- TheraGenesis Wound Matrix$134
- AUGMENT INJECTABLE$130
- Vemlidy$125
- STEGLATRO$125
- KRYSTEXXA$125
- CellerateRx$117
How this compares
$8,616 in reported general payments places this provider in the 80th percentile of 652 foot & ankle surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Epolamine | 742 | $547,052 |
| CiclopiroxCiclopirox Olamine | 5,238 | $224,672 |
| Diclofenac Sodium | 2,025 | $152,652 |
| Ammonium Lactate | 4,799 | $149,334 |
| Ciclopirox | 2,168 | $104,423 |
| Clobetasol Propionate | 269 | $48,758 |
| Tavaborole | 97 | $46,392 |
| Oxiconazole Nitrate | 88 | $36,435 |
| Alcohol Prep PadsAlcohol Antiseptic Pads | 897 | $28,866 |
| JubliaEfinaconazole | 12 | $22,164 |
| Clotrimazole | 725 | $21,765 |
| SantylCollagenase Clostridium Hist. | 44 | $17,607 |
| Ketoconazole | 226 | $10,538 |
| Lidocaine | 121 | $10,239 |
| Alcohol PadsAlcohol Antiseptic Pads | 254 | $9,542 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $21 | $22,16412 claims |
| Smith+NephewSantyl | $391 | $17,60744 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 652 foot & ankle surgery providers in New York.
Other foot & ankle surgery in New York
- Jonathan DelandNew York$4.1M
- Constantine DemetracopoulosNew York$888K
- Anne JohnsonNew York$815K
- Scott EllisNew York$644K
- John KennedyNew York$613K
- Stuart MogulNew York$131K
- Deena HornNew York$93K
- John DoolanNew York$87K
- Jason SnyderNew York$79K
- Meghan KellyNew York$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.